Vasoactive Intestinal Peptide Tumors
Also known as: Vipoma / Vasoactive intestinal peptide-secreting tumor (disorder) / Vipoma, malignant (morphologic abnormality) / Vipoma of uncertain behavior (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB00104 | Octreotide | A peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00104 | Octreotide | Myeloperoxidase | enzyme |
DB00104 | Octreotide | Cytochrome P450 3A4 | enzyme |
DB00104 | Octreotide | Somatostatin receptor | target |
DB00104 | Octreotide | Serum albumin | carrier |
DB00104 | Octreotide | P-glycoprotein 1 | transporter |
DB00104 | Octreotide | Canalicular multispecific organic anion transporter 1 | transporter |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17969 | Edotreotide | 2 | Withdrawn | 1 |
DB13982 | Lutetium Lu-177 | 2 | Withdrawn | 1 |